Identifying ESR1 Mutations to Determine Resistance in HR+ Metastatic Breast Cancer
Cancer Therapy Advisor,
By Clinical Content Hub The global disease burden of breast cancer (BC) is a serious health concern worldwide, especially among…
By Clinical Content Hub The global disease burden of breast cancer (BC) is a serious health concern worldwide, especially among…
The combination of alpelisib plus endocrine therapy elicited a clinical benefit across all subgroups of patients with hormone…
The thresholds for genomic instability scores in triple-negative breast cancer (TNBC) are similar to those in ovarian cancer…
The strategy of simultaneously exploiting deficient DNA damage repair and unleashing the immune response could expand treatment…